|
Objectives
Participants will know the incidence and risk factors for CTEPH
Explain the mechanisms of PH in chronic thromboembolic disease
Know the current and upcoming options for long term anticoagulation
Integrate an understanding of physiological concepts into the management of patients with CTEPH
Able to evaluate the surgical options for CTEPH
Goals
Learn to recognize and evaluate CTEPH
Review the current approach for the assessment of CTEPH
Update on the new anticoagulation medications available for venous thromboembolic disease
Increase knowledge in the role of radiology for CTEPH
Describe recent advances in the medical and surgical management of CTEPH
Target Audience
Practitioners interested in learning more about advances in the understanding of the pathophysiology and treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH).
Cardiologists, respirologists, thoracic surgeons, rheumatologists, internists, hematologists
宗旨
与会者将了解CTEPH的发病率和危险因素
解释PH值在慢性血栓栓塞性疾病的机制
长期抗凝了解当前和未来的选择
CTEPH患者的管理纳入一个生理概念的理解
能够评价CTEPH的手术方案
目标
了解，认识和评价CTEPH
检讨目前CTEPH评估方法
静脉血栓栓塞性疾病提供新的抗凝药物的更新
增加CTEPH放射作用的认识
描述在CTEPH的医疗和手术的管理的最新进展
目标受众
有兴趣了解更多有关慢性栓塞性肺动脉高压（CTEPH）患者的病理生理和治疗的认识的进步执业。
心脏病，血栓，胸外科医师，风湿科，内科，血液科
|
